Sage Therapeutic Stock Market Value
| SAGE Stock | USD 5.47 0.08 1.44% |
| Symbol | Sage |
Sage Therapeutic Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sage Therapeutic. If investors know Sage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sage Therapeutic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.57) | Revenue Per Share 1.76 | Quarterly Revenue Growth 3.371 | Return On Assets (0.30) | Return On Equity (0.49) |
The market value of Sage Therapeutic is measured differently than its book value, which is the value of Sage that is recorded on the company's balance sheet. Investors also form their own opinion of Sage Therapeutic's value that differs from its market value or its book value, called intrinsic value, which is Sage Therapeutic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sage Therapeutic's market value can be influenced by many factors that don't directly affect Sage Therapeutic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sage Therapeutic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sage Therapeutic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sage Therapeutic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Sage Therapeutic 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sage Therapeutic's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sage Therapeutic.
| 11/02/2024 |
| 12/02/2024 |
If you would invest 0.00 in Sage Therapeutic on November 2, 2024 and sell it all today you would earn a total of 0.00 from holding Sage Therapeutic or generate 0.0% return on investment in Sage Therapeutic over 30 days. Sage Therapeutic is related to or competes with Apellis Pharmaceuticals, Terns Pharmaceuticals, Day One, Blueprint Medicines, Amylyx Pharmaceuticals, Relay Therapeutics, and Stoke Therapeutics. Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous sys... More
Sage Therapeutic Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sage Therapeutic's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sage Therapeutic upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 30.67 | |||
| Value At Risk | (6.27) | |||
| Potential Upside | 6.39 |
Sage Therapeutic Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sage Therapeutic's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sage Therapeutic's standard deviation. In reality, there are many statistical measures that can use Sage Therapeutic historical prices to predict the future Sage Therapeutic's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.71) | |||
| Total Risk Alpha | (1.23) | |||
| Treynor Ratio | (0.22) |
Sage Therapeutic Backtested Returns
Sage Therapeutic owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.098, which indicates the firm had a -0.098% return per unit of risk over the last 3 months. Sage Therapeutic exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sage Therapeutic's Variance of 22.17, coefficient of variation of (1,075), and Risk Adjusted Performance of (0.06) to confirm the risk estimate we provide. The entity has a beta of 2.02, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Sage Therapeutic will likely underperform. At this point, Sage Therapeutic has a negative expected return of -0.46%. Please make sure to validate Sage Therapeutic's treynor ratio, accumulation distribution, price action indicator, as well as the relationship between the potential upside and day median price , to decide if Sage Therapeutic performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.5 |
Modest reverse predictability
Sage Therapeutic has modest reverse predictability. Overlapping area represents the amount of predictability between Sage Therapeutic time series from 2nd of November 2024 to 17th of November 2024 and 17th of November 2024 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sage Therapeutic price movement. The serial correlation of -0.5 indicates that about 50.0% of current Sage Therapeutic price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.5 | |
| Spearman Rank Test | -0.56 | |
| Residual Average | 0.0 | |
| Price Variance | 0.11 |
Sage Therapeutic lagged returns against current returns
Autocorrelation, which is Sage Therapeutic stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Sage Therapeutic's stock expected returns. We can calculate the autocorrelation of Sage Therapeutic returns to help us make a trade decision. For example, suppose you find that Sage Therapeutic has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Sage Therapeutic regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Sage Therapeutic stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Sage Therapeutic stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Sage Therapeutic stock over time.
Current vs Lagged Prices |
| Timeline |
Sage Therapeutic Lagged Returns
When evaluating Sage Therapeutic's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Sage Therapeutic stock have on its future price. Sage Therapeutic autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Sage Therapeutic autocorrelation shows the relationship between Sage Therapeutic stock current value and its past values and can show if there is a momentum factor associated with investing in Sage Therapeutic.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Sage Therapeutic is a strong investment it is important to analyze Sage Therapeutic's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Sage Therapeutic's future performance. For an informed investment choice regarding Sage Stock, refer to the following important reports:Check out Sage Therapeutic Correlation, Sage Therapeutic Volatility and Sage Therapeutic Alpha and Beta module to complement your research on Sage Therapeutic. For information on how to trade Sage Stock refer to our How to Trade Sage Stock guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Sage Therapeutic technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.